IL7R and chronic obstructive pulmonary disease: Compared with patients with mild COPD (GOLD I), 29%, 59%, or 70% reduced median lnc-IL7R expression was observed in patients with moderate (GOLD II), severe (GOLD III), or very severe (GOLD IV) COPD, respectively (Table 1, also see Supplementary Table S1).